Repaglinide/metformin fixed-dose combination to improve glycemic control in patients with type 2 diabetes: an update

Evaluation of vildagliptin and fixed dose combination of vildagliptin and metformin on glycemic control and insulin dose over three months in patients with type 2 diabetes mellitus′

Indian Journal of Endocrinology and Metabolism ◽

10.4103/2230-8210.103040 ◽

2012 ◽

Vol 16 (6) ◽

pp. 1048 ◽

Cited By ~ 1

Author(s):

Vishal Mundra

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Glycemic Control ◽

Insulin Dose ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Evaluation of vildagliptin and fixed dose combination of vildagliptin and metformin on glycemic control and insulin dose over 3 months in patients with type 2 diabetes mellitus

Indian Journal of Endocrinology and Metabolism ◽

10.4103/2230-8210.94258 ◽

2012 ◽

Vol 16 (7) ◽

pp. 110 ◽

Cited By ~ 5

Author(s):

Paresh Ved ◽

Samrat Shah

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Glycemic Control ◽

Insulin Dose ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Effect of Switching From an Anti-Diabetic Loose Dose Combination to a Fixed Dose Combination Regimen at Equivalent Dosage for 6 Months on Glycemic Control in Japanese Patients With Type 2 Diabetes: A Pilot Study

Journal of Clinical Medicine Research ◽

10.14740/jocmr3067w ◽

2017 ◽

Vol 9 (8) ◽

pp. 719-724 ◽

Cited By ~ 2

Author(s):

Kazutaka Aoki ◽

Mieko Nagakura ◽

Masataka Taguri ◽

Hiroshi Kamiyama ◽

Makoto Masumura ◽

...

Keyword(s):

Type 2 Diabetes ◽

Pilot Study ◽

Glycemic Control ◽

Japanese Patients ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Combination Regimen ◽

Repaglinide/metformin fixed-dose combination to improve glycemic control in patients with type 2 diabetes: an update

Diabetes Metabolic Syndrome and Obesity Targets and Therapy ◽

10.2147/dmsott.s6621 ◽

2010 ◽

pp. 145 ◽

Cited By ~ 3

Author(s):

Robert Moses

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Evaluation of vildagliptin and fixed dose combination of vildagliptin and metformin on glycemic control and insulin dose over 3 months in patients with type 2 diabetes mellitus

Indian Journal of Endocrinology and Metabolism ◽

10.4103/2230-8210.107877 ◽

2013 ◽

Vol 17 (1) ◽

pp. 178

Author(s):

Paresh Ved ◽

Samrat Shah

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Glycemic Control ◽

Insulin Dose ◽

Fixed Dose Combination ◽

Fixed Dose ◽

The hypolipidemic and hepatoprotective efficacies of a fixed-dose combination of essential phospholipids with methionine (EPL+M) during atorvastatin (A) therapy in hyperlipidemic patients with cardiovascular diseases (CVD) and type 2 diabetes mellitus (DM) (OLYMP trial)

Endocrine Abstracts ◽

10.1530/endoabs.49.ep598 ◽

2017 ◽

Author(s):

M G Bubnova ◽

D M Aronov ◽

Marina Bubnoa ◽

David Aronov

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Cardiovascular Diseases ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Dose Combination ◽

Essential Phospholipids

135-OR: The Effect of Fixed-Dose Combination of Insulin Degludec and Liraglutide on Serum Lipoprotein Metabolism in Patients with Type 2 Diabetes Mellitus

Diabetes ◽

10.2337/db20-135-or ◽

2020 ◽

Vol 69 (Supplement 1) ◽

pp. 135-OR

Author(s):

ELENI PAPPA ◽

CHRISTINA KOSTARA ◽

CONSTANTINOS TELLIS ◽

ALEXANDROS D. TSELEPIS ◽

ELENI BAIRAKTARI ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Lipoprotein Metabolism ◽

Serum Lipoprotein ◽

Insulin Degludec ◽

Fixed Dose Combination ◽

Fixed Dose ◽

BLOOD PRESSURE LOWERING RESPONSE WITH THE FIXED DOSE COMBINATION PERINDOPRIL/INDAPAMIDE IN THAI PATIENTS WITH TYPE 2 DIABETES AND ADDED RISK FACTORS: PP.5.190

Journal of Hypertension ◽

10.1097/01.hjh.0000378514.03077.46 ◽

2010 ◽

Vol 28 ◽

pp. e105

Author(s):

V Ophascharoensuk ◽

K Phimda

Keyword(s):

Risk Factors ◽

Blood Pressure ◽

Type 2 Diabetes ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Blood Pressure Lowering ◽

Pressure Lowering ◽

Sitagliptin and Metformin in Fixed Dose Combination: The Emerging Evidence of its Therapeutic Impact in Type 2 Diabetes

Clinical Medicine Reviews in Vascular Health ◽

10.4137/cmrvh.s3372 ◽

2010 ◽

Vol 2 ◽

pp. 201-215

Author(s):

Baptist Gallwitz

Keyword(s):

Type 2 Diabetes ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Therapeutic Impact ◽

Fixed‐dose combination of empagliflozin and linagliptin for the treatment of patients with type 2 diabetes mellitus: A systematic review and meta‐analysis

Diabetes Obesity and Metabolism ◽

10.1111/dom.13989 ◽

2020 ◽

Vol 22 (6) ◽

pp. 1001-1005

Author(s):

Niki Katsiki ◽

Richard Ofori‐Asenso ◽

Ele Ferrannini ◽

Mohsen Mazidi

Keyword(s):

Diabetes Mellitus ◽

Systematic Review ◽

Type 2 Diabetes ◽

Meta Analysis ◽

Fixed Dose Combination ◽

Fixed Dose ◽